DNLI
Denali Therapeutics Inc. Common Stock ยท Health Care ยท NASDAQ
$24.05
โฒ $0.74 (+3.17%)
Market cap
$3.7B
52-week range
$12.58 โ $24.65
Volume
1.6M
Previous close
$23.31
Denali Therapeutics Inc. Common Stock (DNLI) is held by 2 tracked hedge fund(s). Sector: Health Care. Largest tracked holder: Temasek Holdings (Private) Ltd.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| Temasek Holdings (Private) Ltd Temasek Holdings (Private) Ltd |
0.4% | 7.0M | $135M | โ | $23.04 | 2026-03-31 |
| BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP |
0.4% | 3.7M | $72M | โ | $23.04 | 2026-03-31 |
FAQ โพ
Which hedge funds hold DNLI?
Tracked holders include: Temasek Holdings (Private) Ltd, BAKER BROS. ADVISORS LP.
How much smart money owns DNLI?
2 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading DNLI?
No tracked Congressional trades in DNLI on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings ยท Not investment advice โพ
Ownership from SEC filings; price from market data.
Published by WealthFile ยท Not investment advice.